Ester Cerdeira Sabino Selected Research

Ester Cerdeira Sabino Research Topics

Disease

12	Chagas Disease (American Trypanosomiasis) 01/2022 - 01/2015
9	Infections 01/2022 - 11/2004
5	Chagas Cardiomyopathy 01/2022 - 01/2016
5	COVID-19 01/2022 - 01/2020
4	Heart Failure 01/2020 - 01/2016
3	Sickle Cell Anemia (Hemoglobin S Disease) 04/2022 - 01/2019
3	Inflammation (Inflammations) 04/2022 - 01/2021
2	Reinfection 02/2022 - 01/2021
2	Dengue (Dengue Fever) 01/2021 - 05/2015
2	Shock 01/2021 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 01/2018
2	Parasitemia 11/2018 - 11/2016
2	Anemia 09/2015 - 04/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 03/2014 - 09/2006
1	Leg Ulcer 04/2022
1	Osteomyelitis 04/2022
1	Convalescence 02/2022
1	Oligohydramnios 01/2022
1	Fetal Distress 01/2022
1	Premature Birth (Birth, Premature) 01/2022
1	Hypotension (Low Blood Pressure) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Nausea 01/2021
1	Pharyngitis (Sore Throat) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Maternal Death 01/2021
1	Communicable Diseases (Infectious Diseases) 10/2020
1	Acute Chest Syndrome 01/2020
1	Constrictive Pericarditis 01/2020
1	Priapism 12/2019
1	Yellow Fever 11/2019
1	Hemolysis 08/2019
1	Transfusion Reaction 01/2019
1	Obesity 01/2019
1	Thalassemia 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 12/2018
1	Heart Diseases (Heart Disease) 11/2018
1	Cardiomyopathies (Cardiomyopathy) 11/2018
1	Viremia 12/2016
1	Persistent Infection 08/2016

Drug/Important Bio-Agent (IBA)

6	Immunoglobulin G (IgG)IBA 02/2022 - 01/2015
5	AntibodiesIBA 02/2022 - 05/2009
5	benzonidazole (benznidazole)IBA 01/2022 - 01/2016
4	Neutralizing AntibodiesIBA 01/2022 - 12/2016
4	AntigensIBA 06/2021 - 01/2015
3	pro-brain natriuretic peptide (1-76)IBA 11/2018 - 01/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2016
2	Immunoglobulin M (IgM)IBA 07/2021 - 05/2015
2	EpitopesIBA 06/2021 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
2	VaccinesIBA 01/2021 - 09/2006
2	EnzymesIBA 01/2021 - 11/2004
2	Galectin 3 (LGALS3)IBA 01/2021 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 04/2009
2	RNA (Ribonucleic Acid)IBA 05/2015 - 11/2004
2	Pharmaceutical PreparationsIBA 05/2009 - 11/2004
1	Local Anti-Infective Agents (Antiseptics)IBA 04/2022
1	Soaps (Soap)IBA 04/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022
1	COVID-19 VaccinesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 06/2021
1	InterferonsIBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	brequinarIBA 01/2021
1	Dihydroorotate DehydrogenaseIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	NucleoproteinsIBA 01/2021
1	CytokinesIBA 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021
1	Nucleic AcidsIBA 01/2020
1	amsonic acid (DAS)IBA 01/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2020
1	16S Ribosomal RNAIBA 01/2020
1	Genetic Markers (Genetic Marker)IBA 12/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019
1	betaglycan (TGFBR3)IBA 12/2019
1	SofosbuvirIBA 11/2019
1	RH-antibodiesIBA 08/2019
1	AgarIBA 01/2019
1	acetylcelluloseIBA 01/2019
1	Citric Acid (Citrate)FDA LinkGeneric 01/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	GadoliniumIBA 01/2018
1	Radioisotopes (Radionuclides)IBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 12/2016
1	KynurenineIBA 12/2016
1	Antiviral Agents (Antivirals)IBA 08/2016

Therapy/Procedure

4	Blood Transfusion (Blood Transfusions) 09/2015 - 11/2004
3	Therapeutics 01/2020 - 11/2016
2	Contraindications 12/2018 - 01/2018
1	Length of Stay 01/2022
1	Ambulatory Care (Outpatient Care) 11/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Bariatric Surgery 01/2019
1	Lung Transplantation 12/2018